Brian Bressler - Concepedia

Author

Brian Bressler

Also Known As

B BRESSLER, B Bressler, B. BRESSLER, B. Bressler, B.L. Bressler, Bressler Brian, Brian B Bressler, Brian Bressler, Brian L. Bressler, Noemi Baffy

445

Publications

12K

Citations

H-Index

103

Concepts

All Affiliations

University of British Columbia University of Toronto Western University University of Calgary St. Paul's Hospital

About

Brian Bressler is an author at University of British Columbia specializing in medicine, gastroenterology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	37	3.1K
2	Public Health	5	5	712
3	Health Sciences	2	2	371
4	Social Sciences	1	1	44
5	Biomedical Engineering	1	1	44

Brian Bressler

Publications

8.8K

Citations

H-Index

Page 1

	Year	Citations
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease William J. Sandborn, Brian G. Feagan, Paul Rutgeerts, New England Journal of Medicine	2013	2.6K
Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based Analysis Brian Bressler, Lawrence Paszat, Zhongliang Chen, Gastroenterology EpidemiologyColorectal CancersCancer ScreeningMedicineEpidemiology Of Cancer	2007	623
Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial Reena Khanna, Brian Bressler, Barrett G. Levesque, The Lancet InflammationChronic Inflammatory DiseasesAutoimmune DiseaseMucosal ImmunologyImmunosuppressive Therapy	2015	452
High Body Mass Index Is An Independent Risk Factor for Nonresponse to Antiviral Treatment in Chronic Hepatitis C Brian Bressler, Maha Guindi, George Tomlinson, Hepatology Antiviral TreatmentBody CompositionHepatologyHepatitis CViral Hepatitis	2003	359
Colonoscopic miss rates for right-sided colon cancer: A population-based analysis Brian Bressler, Lawrence Paszat, Christopher Vinden, Gastroenterology Cancer ScreeningColorectal SurgeryMedicineGastroenterologyColorectal Cancer	2004	335
Appropriate Therapeutic Drug Monitoring of Biologic Agents for Patients With Inflammatory Bowel Diseases Konstantinos Papamichael, Adam S. Cheifetz, Gil Melmed, Clinical Gastroenterology and Hepatology	2019	319
Prevalence of Anxiety and Depression in Patients with Inflammatory Bowel Disease Glynis Byrne, Greg Rosenfeld, Yvette Leung, Canadian Journal of Gastroenterology and Hepatology	2017	226
Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections Joshua R. Korzenik, Daniel H. Solomon, Claire Canning, Alimentary Pharmacology & Therapeutics	2009	210
A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis Paul Rutgeerts, Richard N. Fedorak, Daan W. Hommes, Gut	2012	150
Vedolizumab and Anti-Tumour Necrosis Factor α Real-World Outcomes in Biologic-Naïve Inflammatory Bowel Disease Patients: Results from the EVOLVE Study Brian Bressler, Andrés Yarur, Mark S. Silverberg, Journal of Crohn s and Colitis	2021	139

Page 1